Tower Research Capital LLC (Trc) Kiora Pharmaceuticals Inc Transaction History

Tower Research Capital LLC (Trc)

  • $5.8 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$0.36 - $0.68 $690 - $1,303
1,917 Added 18.02%
12,558 $6,000
Q1 2022

May 12, 2022
BUY
$0.54 - $1.27 $5,558 - $13,073
10,294 Added 2966.57%
10,641 $7,000
Q4 2021

Feb 14, 2022
BUY
$0.86 - $2.11 $298 - $732
347 New
347 $1,000

About KIORA PHARMACEUTICALS INC

KPRX Quotes by TradingView
  • Ticker KPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 919,078
  • Market Cap $3.43M
  • Description
  • Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, develops and commercializes therapies for the treatment of ophthalmic diseases in the United States. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 1 clinical trial that acts as a photoswitch to restore vision in patients ...
More about KPRX
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email